ARDELYX INC. - COMMON STOCK
6.3100
25-April-24 15:59:59
15 minutes delayed
Stocks
-0.1200
-1.87%
Today's range
6.2300 - 6.4500
ISIN
N/A
Source
NASDAQ
-
NetDania - New 12 months High: ARDELYX INC. - COMMON STOCK
18 Dec 2023 09:45:08 By NetDania Notify
-
NetDania - New 12 months High: ARDELYX INC. - COMMON STOCK
15 Dec 2023 09:45:15 By NetDania Notify
-
NetDania - New 12 months High: ARDELYX INC. - COMMON STOCK
14 Dec 2023 09:45:03 By NetDania Notify
-
NetDania - New 12 months High: ARDELYX INC. - COMMON STOCK
13 Dec 2023 09:47:25 By NetDania Notify
-
NetDania - New 12 months High: ARDELYX INC. - COMMON STOCK
07 Dec 2023 09:45:06 By NetDania Notify
-
NetDania - New 12 months High: ARDELYX INC. - COMMON STOCK
06 Dec 2023 12:28:31 By NetDania Notify
-
Ardelyx, Inc. Reports Employment Inducement Grants
21 Nov 2023 16:02:00 By Nasdaq GlobeNewswire
-
Ardelyx to Participate at the Piper Sandler 35th Annual Healthcare Conference
21 Nov 2023 08:01:45 By Nasdaq GlobeNewswire
-
15 Nov 2023 16:02:00 By Nasdaq GlobeNewswire
-
Ardelyx Announces Departure of Board Member
13 Nov 2023 16:02:00 By Nasdaq GlobeNewswire
-
Ardelyx to Participate at the Jefferies London Healthcare Conference
10 Nov 2023 08:05:00 By Nasdaq GlobeNewswire
-
Ardelyx Announces XPHOZAH® (tenapanor) Now Available in the United States
06 Nov 2023 08:00:00 By Nasdaq GlobeNewswire
-
03 Nov 2023 08:00:00 By Nasdaq GlobeNewswire
-
31 Oct 2023 07:00:01 By Nasdaq GlobeNewswire
-
Ardelyx, Inc. Reports Employment Inducement Grants
30 Oct 2023 17:42:57 By Nasdaq GlobeNewswire
-
23 Oct 2023 08:07:01 By Nasdaq GlobeNewswire
-
Ardelyx to Report Third Quarter 2023 Financial Results on October 31, 2023
18 Oct 2023 16:02:39 By Nasdaq GlobeNewswire
-
17 Oct 2023 19:23:38 By Nasdaq GlobeNewswire
-
FDA Approves XPHOZAH® (tenapanor), a First-in-Class Phosphate Absorption Inhibitor
17 Oct 2023 19:01:06 By Nasdaq GlobeNewswire
-
13 Oct 2023 08:00:00 By Nasdaq GlobeNewswire